Methylxanthine bronchodilator1-CMT PopPKOralPulmonology

TehopyllineTest

Indication: Asthma, COPD, neonatal apnea

Interactive PK simulator for theophylline based on Rovei et al. (1982) dose-range study. One-compartment oral model with smoking covariate.

Drug Overview

Clinical Context

Molecular Target
Phosphodiesterase / Adenosine receptors
Drug Class
Methylxanthine bronchodilator
Therapeutic Area
Pulmonology
Indication
Asthma, COPD, neonatal apnea
Route of Administration
Oral

Model Information

Model Type
1-CMT PopPK

This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.

About This Simulator

This interactive pharmacokinetic simulator for TehopyllineTest allows you to explore concentration-time profiles under different dosing scenarios. The underlying 1-CMT PopPK model characterizes the pharmacokinetics of this methylxanthine bronchodilator following oral administration.

Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).

Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.

Frequently Asked Questions

What is the TehopyllineTest PK simulator?

This is a free, interactive pharmacokinetic simulator for TehopyllineTest used in Asthma, COPD, neonatal apnea. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.

What drug class does TehopyllineTest belong to?

TehopyllineTest is classified as a Methylxanthine bronchodilator that targets Phosphodiesterase / Adenosine receptors. It is used in the Pulmonology therapeutic area.

What route of administration does this model simulate?

This simulator models Oral administration of TehopyllineTest. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.

What type of PK model is used?

This simulator uses a 1-CMT PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.

Is this simulator free to use?

Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.

Can I use this for clinical dosing decisions?

No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.

Related Simulators

Ready to Simulate?

Launch the TehopyllineTest simulator to explore dosing scenarios and pharmacokinetic profiles interactively.

🚀 Launch Simulator

Comments

0/2000
Loading comments...

⚠️ Disclaimer

This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.

Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community